Although there are potential candidates (osteocalcin, AGEs, and insulin) for such purposes, it is unclear whether or not they could predict the occurrence of new fractures in T2DM patients in a prospective fashion and can be used in daily practice. Here, BGLAP is linked to type 2 diabetes mellitus.